Search
Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.
Today is the fourth anniversary of same-sex marriage being legalized in the United States. Today also marks the start of WorldPride, which celebrates the progress made toward LGBTQ+ equality while underscoring changes still needed.
At Memorial Sloan Kettering Cancer Center’s 46th annual ceremony, graduating master's and PhD students were honored and award winners were recognized.
Learn how MSK is helping a young mother cope with rectal cancer through the Center for Young Onset Colorectal Cancer, the first program in the country devoted to younger adults with this disease.
The genome-editing technique uncovered several genes previously not known to influence embryonic development.
Meet the students who were awarded fellowships based on academic excellence for the 2020–2021 academic year.
The targeted therapy adagrasib received accelerated approved for colorectal cancer caused by a mutation called KRAS-G12C, when used in combination with the drug cetuximab. MSK investigators have led much of the research that resulted in this combined drug approval.
La terapia dirigida adagrasib recibió una aprobación acelerada para el cáncer colorrectal causado por una mutación llamada KRAS-G12C, cuando se usa en combinación con el fármaco cetuximab. Los investigadores de MSK han liderado gran parte de la investigación que llevó a la aprobación de esta combinación de fármacos.
Open to patients in January 2020, the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center provides nearly every aspect of cancer care under one roof.
A new treatment is approved for an especially aggressive kind of colorectal cancer.